Adagio Medical Holdings Inc (ADGM) Shares on the Rise: Short-term Analysis

Ulysses Smith

Adagio Medical Holdings Inc [ADGM] stock is trading at $1.18, up 41.95%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ADGM shares have gain 30.53% over the last week, with a monthly amount glided 50.38%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Adagio Medical Holdings Inc [NASDAQ: ADGM] stock has seen the most recent analyst activity on December 02, 2025, when Lake Street initiated its Buy rating and assigned the stock a price target of $4.

Adagio Medical Holdings Inc [ADGM] stock has fluctuated between $0.62 and $2.87 over the past year. Adagio Medical Holdings Inc [NASDAQ: ADGM] shares were valued at $1.18 at the most recent close of the market.

Analyzing the ADGM fundamentals

Adagio Medical Holdings Inc [NASDAQ:ADGM] reported sales of 0.14M for the trailing twelve months, which represents a drop of -100.00%. Gross Profit Margin for this corporation currently stands at 7.47% with Operating Profit Margin at 479.85%, Pretax Profit Margin comes in at 506.58%, and Net Profit Margin reading is 521.55%. To continue investigating profitability, this company’s Return on Assets is posted at -2.36, Equity is -7.52 and Total Capital is -3.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-16.74.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.0033 points at the first support level, and at 0.8267 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.3033, and for the 2nd resistance point, it is at 1.4267.

Ratios To Look Out For

For context, Adagio Medical Holdings Inc’s Current Ratio is 0.84. In addition, the Quick Ratio stands at 0.68 and the Cash Ratio stands at 0.48. Considering the valuation of this stock, the price to sales ratio is 178.55.

Transactions by insiders

Recent insider trading involved Usen Todd, Chief Executive Officer, that happened on Dec 12 ’25 when 0.21 million shares were purchased.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.